The Technical Analyst
Select Language :
Accelerate Diagnostics [AXDX]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices

Accelerate Diagnostics Price, Forecast, Insider, Ratings, Fundamentals & Signals

Accelerate Diagnostics is listed at the  Exchange

-1.98% $0.990

America/New_York / 28 mar 2024 @ 16:00


Accelerate Diagnostics: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 20.07 mill
EPS: -5.52
P/E: -0.180
Earnings Date: Mar 27, 2024
SharesOutstanding: 20.27 mill
Avg Daily Volume: 0.128 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Strong Buy
DE: Strong Sell
P/E: Strong Buy
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debtn/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.180 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.180 | industry: PE 222.16
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.841 - 1.139

( +/- 15.05%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-05 Patience David Buy 37 468 Employee Restricted Stock Units
2024-03-05 Mertz Larry Michael Buy 40 633 Employee Restricted Stock Units
2024-03-05 Phillips Jack Buy 119 856 Employee Restricted Stock Units
2024-02-26 Patience David Buy 1 000 Common Stock
2024-02-26 Patience David Sell 350 Common Stock
INSIDER POWER
98.62
Last 97 transactions
Buy: 52 782 846 | Sell: 375 597

Forecast: 16:00 - $0.995

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.995
Forecast 2: 16:00 - $0.995
Forecast 3: 16:00 - $0.995
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.990 (-1.98% )
Volume 0.0866 mill
Avg. Vol. 0.128 mill
% of Avg. Vol 67.58 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Accelerate Diagnostics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Accelerate Diagnostics Inc

RSI

Intraday RSI14 chart for Accelerate Diagnostics Inc

Last 10 Buy & Sell Signals For AXDX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Accelerate Diagnostics Inc

AXDX

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Last 10 Buy Signals

Date Signal @
XCADUSDMar 29 - 08:091.460
SFUNDUSDMar 29 - 08:09$4.55
STRKUSDMar 29 - 08:09$14.22
LPTUSDMar 29 - 08:10$18.98
PBTCUSDMar 29 - 08:085 553.51
FTMUSDMar 29 - 08:10$0.984
CBKUSDMar 29 - 08:091.088
APTUSDMar 29 - 08:0917.13
DESOUSDMar 29 - 08:0930.87
ETHWUSDMar 29 - 08:094.50

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.